CORC

在结果中检索

CORC

浏览/检索结果: 共47条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
The efficacy of anlotinib in squamous cell carcinoma (SCC) patients with or without hypertension in ALTER0303: Anlotinib as a third-line therapy in patients with advanced non-small cell lung cancer (NSCLC). 会议论文
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), MAY 31-JUN 04, 2019
作者:  Shi, Jianhua;  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
A Retrospective Analysis of Outcomes of Diffuse Large B Cell Lymphoma (DLBCL) in the Elder Patients in China 会议论文
BLOOD, 2018-11-29
作者:  Liu, Peng;  Han, Ying;  Yang, Jianliang;  He, Xiaohui;  Zhang, Changgong
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
A Prognostic Nomogram and Survival Analysis in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients 会议论文
BLOOD, 2018-11-29
作者:  Jiang, Shiyu;  Qin, Yan;  Liu, Peng;  Yang, Jiangliang;  Yang, Sheng
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078 study 会议论文
CANCER RESEARCH, 2018-07-01
作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Plinabulin, a Novel Small Molecule in Development for Chemotherapy-Induced-Neutropenia (CIN) Prevention, Mobilizes CD34+Cells through a Mechanism of Action (MoA) Different from G-CSF and from CXCR4 Inhibition 会议论文
BLOOD, 2018-11-29
作者:  Blayney, Douglas W.;  Ette, Ene;  Ogenstad, Stephan;  Shi, Yuankai;  Du, Lihua
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03
Phase ib study of safety, tolerability and pharmacokinetics of simotinib in patients with advanced non-small cell lung cancer 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Hu, Xingsheng;  Han, Xiaohong;  Zhang, Li;  Ding, Yanhua;  Wang, Hanping
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04
An updated analysis of ICOGEN to demonstrate utility of a blood-based proteomic test to predict outcomes in EGFR TKI treated patients. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Shi, Yuankai;  Han, Xiaohong;  Zhang, Li;  Ding, Lieming;  Dupuis, Nicholas
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04
A phase III trial (ZJBI0009): CMABOO9 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Shi, Yuankai;  Li, Jin;  Xu, Jianming;  Cheng, Ying;  Liu, Wei
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04
A phase 1 trial of JS001, a monoclonal antibody targeting programmed death-1 (PD-1) in patients with advanced or recurrent malignancies. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Yang, Sheng;  Yang, Jianliang;  Han, Ying;  Qin, Yan;  Han, Xiaohong
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace